Acute Coronary Syndrome (ACS) and its Clinical Features Quiz

Shortness of breath is a common symptom of ACS, indicating inadequate oxygen supply to the heart.

Atherosclerosis, the buildup of plaque in arteries, is the leading cause of ACS.

Elevated CK levels in blood tests indicate myocardial damage, a key feature of ACS.

ST-segment changes on ECG are indicative of myocardial ischemia or injury in ACS.

Unstable angina is characterized by chest pain that occurs at rest or with minimal exertion.

Troponin is a specific biomarker indicating myocardial infarction and is commonly used for diagnosis.

Obesity is a known risk factor for ACS, contributing to the development of atherosclerosis.

STEMI is characterized by sustained ST-segment elevation on ECG, indicating ongoing myocardial damage.

Prinzmetal angina is characterized by chest pain episodes, often occurring at night or early morning.

The RCA is commonly involved in Inferior Wall Myocardial Infarction, leading to specific clinical manifestations.

Aspirin is commonly used for pain relief and antiplatelet effects in ACS management.

Numbness in the legs is not a typical symptom of ACS, which primarily presents with chest pain and other cardiac symptoms.

Variant angina involves chest pain at rest with transient ST-segment elevation, often due to coronary artery spasms.

Oxygen therapy helps improve oxygen supply to the heart during ACS episodes.

The LAD artery is frequently involved in STEMI, leading to significant myocardial damage.

ACE inhibitors are crucial for reducing mortality and improving outcomes post-myocardial infarction.

Coronary artery thrombosis, caused by plaque rupture, can lead to severe complications in ACS.

CTA is a common imaging technique for visualizing coronary arteries and detecting blockages in ACS.

P2Y12 inhibitors play a key role in preventing platelet aggregation and are primary in ACS management.

Elevated troponin levels in blood indicate myocardial injury, a critical marker in ACS diagnosis.

PCI is an urgent procedure to reopen blocked coronary arteries and restore blood flow in STEMI.

Troponin is highly sensitive and specific, making it a key biomarker for myocardial injury in ACS.

Echocardiography is a valuable imaging technique for assessing cardiac function and identifying wall motion abnormalities in ACS.

Clopidogrel is an irreversible P2Y12 inhibitor, playing a key role in preventing platelet aggregation in ACS.

Increased QRS voltage on ECG indicates left ventricular hypertrophy and is a risk factor for cardiovascular events in ACS patients.